Your browser doesn't support javascript.
loading
Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention Studies.
Cirrincione, Lauren R; Grieve, Victoria Luna Brennan; Holloway, Jay; Marzinke, Mark A.
Affiliation
  • Cirrincione LR; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Grieve VLB; School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Holloway J; Independent Researcher, Los Angeles, California, USA.
  • Marzinke MA; Department of Medicine, Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Clin Pharmacol Ther ; 113(3): 557-564, 2023 03.
Article in En | MEDLINE | ID: mdl-36416569
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Transgender Persons Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Transgender Persons Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Type: Article Affiliation country: United States